Cellipont and Optieum Collaborate for Innovative CAR-T Therapy Manufacturing Cellipont Bioservices joins forces with Optieum Biotechnologies to enhance the cGMP manufacturing of a new CAR-T therapy targeting glioblastoma. This collaboration aims to revolutionize cancer treatment.

Cellipont and Optieum Collaborate for Innovative CAR-T Therapy Manufacturing #United_States #CAR-T_therapy #The_Woodlands #Cellipont_Bioservices #Optieum_Biotechnologies